Clover Health Investor Day Presentation Deck
Step 3: Further Upside To Economics With Stars
While Clover is rated at 3.0 Stars today, we intend to achieve 4+ Stars over time. The Clover Assistant is expected
to be a significant driver of our success given our release of Stars features over the past year.
(1)
H2 2019
Initial Stars features rolled out including cancer
screenings and flu shot reminders as well as prompt
for physicians to address HOS survey measures
such as discussing fall risk and urinary incontinence
July 2018
Launch of the Clover Assistant with
no Stars features
H2 2020
Rollout of features to
support alc control,
medication adherence, and
transition in care measures
H1 2020
Further HEDIS features released, such as alert for
medication reconciliation post discharge and prompt
to address Diabetic Retinopathy exam. Also support
for mail order given COVID.
I
COVID impact on HEDIS and survey measures has limited
efforts to drive Stars rating
Future Releases
Releases are expected to
continue to address clinical
measures as well as incorporate
survey education
Regulatory Tailwinds
Government support for calculation
methodology changes including 1) local, rather
than national, comparisons, and 2) alternative
weighting methodology for social risk factors,
which are insufficiently accounted for currently
We estimate an improvement from 3.0 to 3.5 Stars and from 3.5 Stars to 4.0 Stars would each yield
~500 bps (total of ~1,000 bps) improvement in revenue to be reinvested into more benefits for our
members, consistent with our growth strategies.
Based on recommendations from the Medicare Payment Advisory Commission, an independent, non-partisan legislative branch agency. The agency released a report to Congress in June
2020 titled, "Medicare and the Health Care Delivery System," in which the Stars program is discussed.
20View entire presentation